LeviSense Medical
LeviSense Medical: Advancing bed ulcer prevention with high-tech, responsive patient bed systems.
Founded
2019LeviSense Medical: Advancing bed ulcer prevention with high-tech, responsive patient bed systems.
LeviSense Medical, founded with the mission to revolutionize the prevention and treatment of pressure ulcers, focuses on developing advanced medical technology. Their flagship product, the LeviSense ProDaptive™ therapeutic mattress, utilizes high-resolution sensing and adaptive surface control to monitor and adjust to a patient's form, position, and movements. This innovative system aims to prevent bed sores by dynamically redistributing pressure, offering enhanced comfort and protection for patients in medical care settings.
Notable figures affiliated with LeviSense Medical include experts in medical technology and healthcare innovation. The company has attracted significant attention from investors interested in transformative healthcare solutions. Key achievements include the development and deployment of the LeviSense SensorCell™ technology, which has been recognized for its potential to significantly improve patient outcomes in pressure injury prevention. Overall, LeviSense Medical is making a substantial impact on patient care by addressing a critical issue with cutting-edge technology.
Companies similar to LeviSense Medical include Wellsense, TheraTorr Medical, Levee Medical and Ulcer Solutions.
LeviSense Medical was founded in 2019.
LeviSense Medical's headquarters is located in Beverly, MA, US.
LeviSense Medical's most recent funding round was for $270k (USD) in March 2022.
As of Mar 22, 2022, LeviSense Medical has disclosed funding of $270k (USD). Undisclosed round amounts are excluded.
LeviSense Medical has 6 employees as of Feb 5, 2024.
Ulcer Solutions
ulcersolutions.com
